HOLLER FRANK A 4
4 · Xenon Pharmaceuticals Inc. · Filed Sep 18, 2019
Insider Transaction Report
Form 4
HOLLER FRANK A
Director
Transactions
- Sale
Common Shares
2019-09-17$9.32/sh−5,069$47,243→ 136,129 total - Award
Stock Option (Right to Buy)
2019-09-16+15,000→ 15,000 totalExercise: $9.44Exp: 2029-09-15→ Common Shares (15,000 underlying) - Sale
Common Shares
2019-09-18$9.28/sh−4,368$40,535→ 131,761 total
Footnotes (3)
- [F1]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $9.25 to $9.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date.